newsfilter
← Latest News
CNBC·

Bill Gates-backed Ginkgo Bioworks going public via $15 billion SPAC

Ginkgo Bioworks is going public via a merger with former MGM CEO Harry Sloan's SPAC in a deal that values the biotech company at $15 billion.